Controversial Report Regarding Seroprevalence of Hepatitis B and C Viruses Among Hemodialysis Patients In Kerman Province, South-East Iran

authors:

avatar Mojgan Noroozi Karimabad 1 , avatar Gholamhossein Hassanshahi 1 , avatar Mohammad Kazemi Arababadi 2 , *

Molecular Medicine Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, IR Iran
Immunology of Infectious Disease Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, IR Iran

how to cite: Noroozi Karimabad M, Hassanshahi G, Arababadi M K. Controversial Report Regarding Seroprevalence of Hepatitis B and C Viruses Among Hemodialysis Patients In Kerman Province, South-East Iran. Hepat Mon. 2013;13(3):e7046. https://doi.org/10.5812/hepatmon.7046.

References

  • 1.

    Zahedi MJ, Darvish Moghaddam S, Alavian SM, Dalili M. Seroprevalence of Hepatitis Viruses B, C, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran. Hepat Mon. 2012;12(5):339-43. [PubMed ID: 22783346]. https://doi.org/10.5812/hepatmon.5969.

  • 2.

    Arababadi MK, Hassanshahi G, Yousefi H. HBV-DNA in hemodialysis patients infected by HCV. Saudi J Kidney Dis Transpl. 2009;20(3):398-401. [PubMed ID: 19414941].

  • 3.

    Pesanti EL. Immunologic defects and vaccination in patients with chronic renal failure. Infect Dis Clin North Am. 2001;15(3):813-32. [PubMed ID: 11570143].

  • 4.

    Liu ML, Xu G, Xue SR, Zhong XC, Chen GX, Chen ZJ. Plasma levels of Th1/Th2 type cytokine are associated with change of prolactin and GH/IGF-I in hemodialysis patients. Int J Artif Organs. 2008;31(4):303-8. [PubMed ID: 18432585].

  • 5.

    Chonchol M. Neutrophil dysfunction and infection risk in end-stage renal disease. Semin Dial. 2006;19(4):291-6. [PubMed ID: 16893406]. https://doi.org/10.1111/j.1525-139X.2006.00175.x.

  • 6.

    Eleftheriadis T, Liakopoulos V, Leivaditis K, Antoniadi G, Stefanidis I. Infections in hemodialysis: a concise review. Part II: blood transmitted viral infections. Hippokratia. 2011;15(2):120-6. [PubMed ID: 22110292].

  • 7.

    Abu El Makarem MA, Abdel Hamid M, Abdel Aleem A, Ali A, Shatat M, Sayed D, et al. Prevalence of occult hepatitis B virus infection in hemodialysis patients from egypt with or without hepatitis C virus infection. Hepat Mon. 2012;12(4):253-8. [PubMed ID: 22690232]. https://doi.org/10.5812/hepatmon.665.

  • 8.

    Altindis M, Uslan I, Cetinkaya Z, Yuksel S, Ciftci IH, Demirturk N, et al. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B]. Mikrobiyol Bul. 2007;41(2):227-33. [PubMed ID: 17682709].

  • 9.

    Ramezani A, Banifazl M, Eslamifar A, Aghakhani A. Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran. J Infect Dev Ctries. 2010;4(10):658-61. [PubMed ID: 21045360].